News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
192 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (3218)
February (3391)
March (3462)
April (3660)
May (4667)
June (3468)
July (2307)
August (2524)
September (2745)
October (3357)
November (3389)
December (2298)
Day
1 (192)
2 (123)
5 (144)
6 (142)
7 (169)
8 (188)
9 (100)
12 (136)
13 (139)
14 (123)
15 (130)
16 (48)
19 (83)
20 (71)
21 (97)
22 (50)
23 (91)
26 (100)
27 (110)
28 (134)
29 (108)
30 (46)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
5
6
7
8
9
12
13
14
15
16
19
20
21
22
23
26
27
28
29
30
Cardiovascular disease
Lilly’s Tirzepatide Clears Phase III Cardiovascular Study on Heels of Novo
Eli Lilly on Thursday released late-stage data showing a 38% reduction in the risk of heart failure outcomes, as it plays catch-up with Novo Nordisk’s semaglutide which won the FDA’s cardio nod in March.
August 1, 2024
·
2 min read
·
Tristan Manalac
Earnings
Moderna Cuts Full-Year Revenue Guidance as COVID-19 Vaccine Sales Crater in Q2
Moderna’s stock price plunged more than 20% in Thursday morning trading after the company lowered its 2024 revenue guidance due to weak demand for its coronavirus vaccine in the second quarter.
August 1, 2024
·
2 min read
·
Tyler Patchen
Press Releases
Processed Red Meat Raises the Risk of Dementia; Swapping It for Nuts and Beans May Lower Risk
August 1, 2024
·
5 min read
Press Releases
Appendix 4C – Q4 FY24 Quarterly Cash Flow Report
August 1, 2024
·
9 min read
Business
Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results
August 1, 2024
·
15 min read
Business
Zymeworks Provides Corporate Update and Reports Second Quarter 2024 Financial Results
August 1, 2024
·
20 min read
Business
Sight Sciences Reports Second Quarter 2024 Financial Results and Narrows Full Year 2024 Financial Guidance
August 1, 2024
·
18 min read
Business
Shattuck Labs Reports Second Quarter 2024 Financial Results and Recent Business Highlights
August 1, 2024
·
10 min read
Business
Xenon to Report Q2 2024 Financial Results on August 8, 2024
August 1, 2024
·
1 min read
Business
Travere Therapeutics Reports Second Quarter 2024 Financial Results
August 1, 2024
·
23 min read
Previous
2 of 20
Next
